The Hydration Pharmaceuticals CoASX:HPC Return-on-Tangible-Asset is -159.59% as of Dec. 2025. The stock has 3 warning signs investors should review. Among 312 Retail - Defensive companies, The Hydration Pharmaceuticals Co ranks worse than 98.4% on this metric.
The historical rank and industry rank for The Hydration Pharmaceuticals Co's Return-on-Tangible-Asset or its related term are showing as below:
ASX:HPC'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -95.33 Med: -76.97 Max: 47.11
Current: -85.93
During the past 5 years, The Hydration Pharmaceuticals Co's highest Return-on-Tangible-Asset was 47.11%. The lowest was -95.33%. And the median was -76.97%.
ASX:HPC's Return-on-Tangible-Asset is ranked worse than 98.4% of 312
companies
in the Retail - Defensive industry
Industry Median: 3.88
vs ASX:HPC: -85.93
The Hydration Pharmaceuticals Co (ASX:HPC) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
The Hydration Pharmaceuticals Co Return-on-Tangible-Asset Related Terms
The Hydration Pharmaceuticals Co Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Hydration Pharmaceuticals Co Return-on-Tangible-Asset Chart
ASX:HPC vs SYY, USFD, PFGC: Return-on-Tangible-Asset Comparison
For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Hydration Pharmaceuticals Co Return-on-Tangible-Asset vs Retail - Defensive Industry
For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where The Hydration Pharmaceuticals Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of -159.59% mean?
The Hydration Pharmaceuticals Co (ASX:HPC) has a Return-on-Tangible-Asset of -159.59% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on The Hydration Pharmaceuticals Co and its competitors. According to the industry distribution chart, The Hydration Pharmaceuticals Co ranks #307 out of 312 companies in the Retail - Defensive industry, placing it in the top 98.4%.
Is The Hydration Pharmaceuticals Co's Return-on-Tangible-Asset too high?
The Hydration Pharmaceuticals Co's current Return-on-Tangible-Asset is -159.59%. Based on the distribution chart, The Hydration Pharmaceuticals Co ranks #307 out of 312 companies in the Retail - Defensive industry, which is in the bottom quartile relative to peers.
How does The Hydration Pharmaceuticals Co's Return-on-Tangible-Asset compare to SYY and USFD?
According to the Retail - Defensive industry distribution chart, The Hydration Pharmaceuticals Co ranks #307 out of 312 companies for Return-on-Tangible-Asset. This places The Hydration Pharmaceuticals Co in the lower half of its industry. The industry median Return-on-Tangible-Asset is 3.88. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Retail - Defensive company?
The median Return-on-Tangible-Asset among Retail - Defensive companies is 3.88, based on 312 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on The Hydration Pharmaceuticals Co and its competitors. For the Retail - Defensive industry, the median Return-on-Tangible-Asset is 3.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Hydration Pharmaceuticals Co's current Return-on-Tangible-Asset is -159.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current Return-on-Tangible-Asset of -159.59%. The current Return-on-Tangible-Asset is -159.59%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current Return-on-Tangible-Asset is -159.59% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Hydration Pharmaceuticals Co Business Description
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:HPC has been successfully added to your 